1. Home
  2. IOVA vs DRH Comparison

IOVA vs DRH Comparison

Compare IOVA & DRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$4.08

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Diamondrock Hospitality Company

DRH

Diamondrock Hospitality Company

HOLD

Current Price

$11.95

Market Cap

1.9B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
IOVA
DRH
Founded
2007
2004
Country
United States
United States
Employees
N/A
35
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.9B
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
IOVA
DRH
Price
$4.08
$11.95
Analyst Decision
Buy
Buy
Analyst Count
10
10
Target Price
$9.00
$10.38
AVG Volume (30 Days)
12.1M
1.6M
Earning Date
05-07-2026
04-30-2026
Dividend Yield
N/A
3.51%
EPS Growth
14.84
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$47.74
$3.44
Revenue Next Year
$40.31
$2.42
P/E Ratio
N/A
$38.41
Revenue Growth
N/A
N/A
52 Week Low
$1.67
$7.45
52 Week High
$5.63
$11.93

Technical Indicators

Market Signals
Indicator
IOVA
DRH
Relative Strength Index (RSI) 53.47 73.90
Support Level $2.07 $9.10
Resistance Level $4.35 N/A
Average True Range (ATR) 0.36 0.24
MACD -0.02 0.05
Stochastic Oscillator 40.45 85.21

Price Performance

Historical Comparison
IOVA
DRH

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

About DRH Diamondrock Hospitality Company

Diamondrock Hospitality Company is a real estate investment trust that owns lodging properties. Its business is to acquire, own, manage, and renovate full-service hotel properties in the United States. It operates in cities such as Chicago, Boston, New York, Denver, and others. Within DiamondRock's holdings, the majority of the hotel brands include Marriott, Starwood, and Hilton. The company operates in one reportable segment: The hotel ownership segment, which is comprised of upper upscale and luxury chain scale hotels that offer hotel rooms, food and beverage and other ancillary guest services.

Share on Social Networks: